Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

For Most Late-Stage Colorectal Cancers Surgery Is Not Necessary
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don"t require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.
generic viagra online
Nonin Medical Announces FDA Clearance For Its Next-Generation Regional Oximetry System
Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, announced FDA clearance for its Model 7600 Regional Oximetry System. Introduced in June 2009 at the European Society of Anaesthesiology (ESA) conference in Milan, Italy, the innovative Model 7600 offers real-time monitoring of cerebral oxygenation for patients at risk of ischemia.
News of the day
CPhA Applauds Efforts To Help Seniors Afford Prescription Medications
Congressional leaders and leading pharmaceutical companies have come up with a plan to reduce medication costs for millions of senior citizens enrolled in the Medicare Part D Prescription Drug program. In combination with other discount programs and rebates, the savings to the U.S. government could represent $80 billion. The Pharmaceutical Research and Manufacturers of America (PhRMA) is leading the charge to specifically close the coverage gap for patients whose medications costs fall into the "doughnut hole."
Health Insurance

Multidisciplinary Cancer Congress

ECCO 15 - ESMO 34 will take place at the ICC Berlin - Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany (http://www.icc-berlin.de) from Sunday 20 September to Thursday 24 September 2009. ECCO 15 - ESMO 34 will build on the success of the previous ECCO (European Cancer Conference) and ESMO (European Society for Medical Oncology) conferences. It provides a unique European forum for presentations of cutting-edge research from experimental and clinical oncologists, epidemiologists and cancer nurses. Over 15,000 scientists, doctors, nurses, patients, carers and industry representatives are expected to attend. More than 100 experts in different cancer fields have developed a wide-ranging and exciting congress programme, with large numbers of reports of translational research and first reports from high quality phase III clinical trials. In addition, for the first time there will be an "oncopolicy" track; this has been introduced to help inform European policy on cancer and to ensure its place at the top of the EU health and research policy agenda. Mary Rice ECCO-the European CanCer Organisation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009